Clinical trials
Completed Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,770 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 44 |
| 2001 | 42 |
| 2002 | 53 |
| 2003 | 92 |
| 2004 | 141 |
| 2005 | 149 |
| 2006 | 167 |
| 2007 | 157 |
| 2008 | 186 |
| 2009 | 171 |
| 2010 | 179 |
| 2011 | 176 |
| 2012 | 171 |
| 2013 | 130 |
| 2014 | 171 |
| 2015 | 156 |
| 2016 | 135 |
| 2017 | 152 |
| 2018 | 158 |
| 2019 | 144 |
| 2020 | 132 |
| 2021 | 158 |
| 2022 | 149 |
| 2023 | 146 |
| 2024 | 98 |
| 2025 | 54 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3,770 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 156 |
| Novartis | 139 |
| Boehringer Ingelheim | 117 |
| AstraZeneca | 59 |
| Novartis Pharmaceuticals | 50 |
| Chong Kun Dang Pharmaceutical | 47 |
| Boryung Pharmaceutical Co., Ltd | 39 |
| Takeda | 37 |
| NYU Langone Health | 34 |
| Johns Hopkins University | 31 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 3,770 |
| Diabetes Mellitus | 462 |
| Cardiovascular Diseases | 459 |
| Obesity | 315 |
| Heart Diseases | 243 |
| Diabetes Mellitus, Type 2 | 212 |
| Dyslipidemias | 153 |
| Hyperlipidemias | 134 |
| Metabolic Syndrome | 123 |
| Essential Hypertension | 114 |
Trials
Showing 76 to 100 of 3,770. Each trial links to its page on Pharma Observatory.
3,670 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.